B-Cell Monoclonal Antibodies and Their Use in Clinical Oncology

References

• Ling NR, MaElennan ICM, Mason DY. B cell antigens: new and previously defined clusters. Leukocyte Typing III, AJ. McMichael. Oxford University Press, Oxford 1987; 302–336
   Google Scholar
• Preud'homme JL, Seligman M. Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases. Blood 1972; 40: 777–791
   PubMed Web of Science ®Google Scholar
• Gathings WE, Lawton AR, Cooper MD. Immunofluorescent studies on the development of pre-B cells. B lymphocytes and immunoglobulin isotype diversity in humans. Eur J Immunol 1977; 7: 804–810
   PubMed Web of Science ®Google Scholar
• Korsmeyer SJ, Hieter PA, Ravetch JV, et al. Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B cells. Proc Natl Acad Sci (USA) 1981; 78: 301–313
   Google Scholar
• Korsmeyer JS, Arnold A, Bakhshi A, et al. Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. J Clin Invest 1983; 71: 301–313
   PubMed Web of Science ®Google Scholar
• Nadler LM, Korsmeyer SJ, Anderson KC, et al. B cell origin of non-T cell acute lymphoblastic leukemia. J Clin Invest 1984; 74: 332–340
   PubMed Web of Science ®Google Scholar
• Brouet JC, Preud'homme JL, Penit C, et al. Acute lymphoblastic leukemia with pre-B cell characteristics. Blood 1979; 54: 269–273
   PubMed Web of Science ®Google Scholar
• Nadler LM, Anderson KC, Marti G, et al. B4, a human B cell associated antigen expressed on normal, mitogen activated, and malignant B lymphocytes. J Immunol 1983; 131: 244–250
   PubMed Web of Science ®Google Scholar
• Stamenkovic I, Seed B. CD19, the earliest differentiation antigen of B cell lineage, bears three extracellular immunoglobulin-like domains and an Epstein-Barr virus related cytoplasmic tail. J Exp Med 1988; 168: 1205–1210
   PubMed Web of Science ®Google Scholar
• Pezzutto A, Dorken G, Rabinovitch PS, et al. CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin induced B cell activation and proliferation. J Immunol 1987; 138: 2793–2799
   PubMed Web of Science ®Google Scholar
• Ledbetter JA, Rabinovitch PS, June CH, et al. Proc Natl Acad Sci (USA) 1988; 85: 1897–1901
   PubMed Web of Science ®Google Scholar
• Hokland P, Rosenthal P, Griffin JD, et al. Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA). J Exp Med 1983; 157: 114–129
   PubMed Web of Science ®Google Scholar
• Hokland P, Nadler LM, Griffin JD, et al. Purification of the common acute lymphoblastic leukemia antigen (CALLA) positive cells from normal bone marrow. Blood 1984; 64: 662–666
   PubMed Web of Science ®Google Scholar
• Ritz J, Pesando M, Notic-McConarty J, et al. A monoclonal antibody to human acute lymphoblastic leukemia antigen. Nature 1980; 283: 583–585
   PubMed Web of Science ®Google Scholar
• Greaves MF, Hariri G, Newman RA, et al. Selective expression of the common acute lymphoblastic leukemia (gp100) antigen on immature lymphoid cells and their malignant counterparts. Blood 1983; 61: 628–639
   PubMed Web of Science ®Google Scholar
• Shipp MA, Barker PE, D'Adamio L, et al. The common acute lymphoblastic leukemia antigen is a membrane-bound zinc metalloprotease that maps to chromosome region 3(q21–27). Blood 1988; 72: 102a
   PubMedGoogle Scholar
• Shipp MA, Vijayaraghavan J, Schmidt E, et al. The common acute lymphoblastic leukemia antigen (CALLA) and ‘enkephalinase’ (membrane-bound neutral endopeptidase 24.11) are identical. Blood 1988; 72: 226a
   Google Scholar
• Stashenko P, Nadler LM, Hardy R, et al. Characterization of a new B lymphocyte specific antigen in man. J Immunol 1980; 125: 1678–1685
   PubMed Web of Science ®Google Scholar
• Nadler LM, Stashenko P, Ritz J, et al. A unique cell surface antigen identifying lymphoid malignancies of B cell origin. J Clin Invest 1981; 67: 134–140
   PubMed Web of Science ®Google Scholar
• Clark EA, Shu G, Ladbetter JA. Role of the Bp35 cell surface polypeptide in human B-cell activation. Proc Natl Acad Sci (USA) 1985; 82: 1766–1770
   PubMed Web of Science ®Google Scholar
• Tedder TF, Boyd AW, Freedman AS, et al. The B cell surface molecule B1 is functionally linked with B cell activation and differentiation. J Immunol 1985; 135: 973–979
   PubMed Web of Science ®Google Scholar
• Tedder TF, Streuli M, Schlossman SF, et al. Isolation and structure of a cDNA encoding the Ba (CD20) cell surface antigen of human B lymphocytes. Proc Natl Acad Sci (USA) 1988; 95: 208–212
   Google Scholar
• Stamenkovic I, Seed B. Analysis of two cDNA clones encoding the B lymphocyte antigen CD20 (B1,Bp35), a type III integral membrane protein. J Exp Med 1988; 167: 1975–1980
   PubMed Web of Science ®Google Scholar
• Einfeld DA, Brown JP, Valentine MA, et al. Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains. EMBO J 1988; 7: 711–717
   PubMed Web of Science ®Google Scholar
• Hokland P, Ritz J, Schlossman SF, et al. Orderly expression of B cell antigens during the in vitro differentiation of non-malignant human pre-B cell. J Immunol 1985; 135: 1746–1751
   PubMed Web of Science ®Google Scholar
• Dorken B, Moldenhauer G, Pezzutto A, et al. HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes. J Immunol 1986; 136: 4470–4479
   PubMed Web of Science ®Google Scholar
• Abramson C, Kersey JH, LeBien TW. A monoclonal antibody (BA-1) primarily reactive with cells of human B lymphocyte lineage. J Immunol 1981; 126: 83–88
   PubMed Web of Science ®Google Scholar
• Moldenhauer G, Dorken B, Schwartz R, . Characterization of a human B cell lymphocyte specific antigen defined by the monoclonal antibodies HD6 and HD39. Leukocyte Typing II, EL. Reinherz, BF. Haynes, LM. Nadler, ID. Bernstein, et al. Springer Verlag, Berlin 1986; vol. 2: 97–107
   Google Scholar
• Pezzutto A, Dorken B, Moldenhauer G, et al. Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140. J Immunol 1987; 138: 98–103
   PubMed Web of Science ®Google Scholar
• Nadler LM, Stashenko P, Hardy R, et al. Characterization of a B cell specific (B2) distinct from Bl. J Immunol 1981; 126: 1941–1947
   PubMed Web of Science ®Google Scholar
• Fingeroth JD, Weis J, Tedder TF, et al. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci (USA) 1984; 81: 4510–4514
   PubMed Web of Science ®Google Scholar
• Nadler LM, Boyd AW, Park E, . The B cell-restricted glycoprotein (B2) is the receptor for Epstein-Barr virus. Leukocyte Typing II., EL. Reinherz, BF. Haynes, LM. Nadler, ID. Bernstein, et al. Springer Verlag, Berlin 1986; 509–513
   Google Scholar
• Iida K, Nadler LM, Nussenzweig V. The identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody. J Exp Med 1983; 158: 1021–1033
   PubMed Web of Science ®Google Scholar
• Frade R, Crevon MC, Barel M, et al. Enhancement of human B cell proliferation by an antibody to the C3d receptor, the gp 140 molecule. Eur J Immunol 1985; 15: 73–76
   PubMed Web of Science ®Google Scholar
• Nemerow GR, McNaughton ME, Cooper NR. Binding of monoclonal antibody to the Epstein Barr virus (EBV) CR2 receptor induces activation and differentiation of human B lymphocytes. J Immunol 1985; 135: 3068–3073
   PubMed Web of Science ®Google Scholar
• Wilson BS, Platt JL, Kay NE. Monoclonal antibodies to the 140,000 mol wt glycoprotein of B lymphocyte membranes (CR2 receptor) initiates proliferation of B cells in vitro. Blood 1985; 66: 824–829
   PubMed Web of Science ®Google Scholar
• Paul WE, Mizuguchi J, Brown M, et al. Regulation of B-lymphocyte activation, proliferation, and immunoglobulin secretion. Cell Immunol 1986; 99: 7–13
   PubMed Web of Science ®Google Scholar
• Boyd AW, Tedder TF, Griffin JD, et al. Pre-exposure of resting B cells to gamma interferon enhances their proliferative response to subsequent activation signals. Cell Immunol 1987; 106: 355–365
   PubMed Web of Science ®Google Scholar
• Freedman AS, Freeman G, Whitman J, et al. Pre-exposure of human B cells to recombinant interleukin I enhances subsequent proliferation. J Immunol 1988; 141: 3398–3404
   PubMed Web of Science ®Google Scholar
• Rabin EM, Ohara J, Paul WE. B-cell stimulatory factor 1 activates resting B cells. Proc Natl Acad Sci (USA) 1985; 82: 2935–2929
   PubMed Web of Science ®Google Scholar
• Defrance T, Aubry JP, Rousset F, et al. Human recombinant interleukin 4 induces FcE receptors (CD23) on normal human B lymphocytes. J Exp Med 1987; 165: 1459–1467
   PubMed Web of Science ®Google Scholar
• Boyd AW, Anderson KC, Freedman AS, et al. Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody. J Immunol 1985; 134: 1516–1523
   PubMed Web of Science ®Google Scholar
• Kehrl JH, Muraguchi A, Fauci AS. Differential expression of cell activation markers after stimulation of resting human B lymphocytes. J Immunol 1984; 132: 2857–2861
   PubMed Web of Science ®Google Scholar
• Haynes BF, Hemler ME, Mann DL, et al. Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J Immunol 1981; 126: 1409–1420
   PubMed Web of Science ®Google Scholar
• Rothlein R, Dustin ML, Marlin SD, et al. A human intracellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol 1986; 137: 1270–1274
   PubMed Web of Science ®Google Scholar
• Thorley-Lawson DA, Schooley RT, Bhan AK, et al. Epstein-Barr virus superinduces a new human B cell differentiation antigen (BLAST-1) expressed on transformed lymphoblasts. Cell 1982; 30: 415–425
   PubMed Web of Science ®Google Scholar
• Tsudo M, Uchiyama T, Uchino H. Expression of TAC antigen on activated normal human B cells. J Exp Med 1984; 160: 612–617
   PubMed Web of Science ®Google Scholar
• Boyd AW, Fisher DC, Fox D, et al. Structural and functional characterization of IL-2 receptors on activated B cells. J Immunol 1985; 134: 2387–2392
   PubMed Web of Science ®Google Scholar
• Freedman AS, Boyd AW, Bieber F, et al. Normal cellular counterparts of B cell chronic lymphocytic leukemia. Blood 1987; 70: 418–27
   PubMed Web of Science ®Google Scholar
• Freedman AS, Freeman G, Whitman J, et al. Studies of in vitro activated CD5+ B cells. Blood 1989; 73: 202–208
   PubMed Web of Science ®Google Scholar
• Thorley-Lawson DA, Nadler LM, Bhan AK, et al. Blast-2 (EBVCS) an early cell surface marker of human B cell activation, is superinduced by Epstein-Barr virus. J Immunol 1985; 134: 3007–3012
   PubMed Web of Science ®Google Scholar
• Freedman AS, Boyd AW, Anderson KC, et al. B5, a new B cell restrited activation antigen. J Immunol 1985; 134: 2228–2235
   PubMed Web of Science ®Google Scholar
• Freedman AS, Freeman G, Horowitz JC, et al. B7, a B cell restricted antigen which identifies pre-activated B cells. J Immunol, 137: 3260–3267
   Google Scholar
• Yokochi T, Holly RD, Clark EA. B lymphoblast antigen (BB1) expressed on Epstein-Barr virus-activated B cell blasts. B lymphoblastoid cell lines, and Burkitt's lymphomas. J Immunol 1982; 128: 823–827
   PubMed Web of Science ®Google Scholar
• Kikutani H, Kimura R, Nakamura H, et al. Expression and function of an early activation marker restricted to human B cells. J Immunol 1986; 136: 4019–4036
   PubMed Web of Science ®Google Scholar
• Suzuki T, Sanders SK, Butler JL, et al. Identification of an early activation antigen (Bac-1) on human B cells. J Immuol 1986; 137: 1208–1213
   PubMed Web of Science ®Google Scholar
• Neckers LM, Yenokida G, James SP. The role of the transferrin receptor in human B lymphocyte activation. J Immunol 1984; 133: 2437–1441
   PubMed Web of Science ®Google Scholar
• Kikutani H, Inui S, Sato R, et al. Molecular structure of human lymphocyte receptor for immunoglobulin E. Cell 1986; 47: 657–665
   PubMed Web of Science ®Google Scholar
• Gordon J, Rowe M, Walker L, et al. Ligation of the CD23 p45 antigen triggers cell-cycle progression of activated B lymphocytes. Eur J Immunol 1986; 16: 1075–1080
   PubMed Web of Science ®Google Scholar
• Swendeman SL, Thorley-Lawson DA. The activation antigen Blast-2, when shed is a BDGF for normal and transformed B-lymphocytes. Leukocyte Typing III., AJ. McMichael. Oxford University Press, Oxford 1987; 453–454
   Google Scholar
• Ikuta K, Takami M, Kim CW, et al. Human lymphocyte Fc receptor for IgE: sequence homology of its cloned cDNA with animal lectins. Proc Natl Acad Sci (USA) 1987; 84: 819–823
   PubMed Web of Science ®Google Scholar
• Clark EA, Yokochi T. Human B cell and B cell blast-associated surface molecules defined with monoclonal antibodies. Leukocyte Typing I., A. Bernard, et al. Springer Verlag, Berlin 1984; 339–346
   Google Scholar
• Marlin SD, Pringer TA. Purified intracellular adhesion molecule-1 (ICAm-1) is a ligand for lymphocyte-functional antigen 1 (LFA-1). Cell 1987; 51: 813–819
   PubMed Web of Science ®Google Scholar
• Patarroyo M, Clark EA, Prieto J, et al. Identification of a novel adhesion molecule in human leukocytes by monoclonal antibody LB-2. FEBS Letters 1987; 210: 127–131
   PubMed Web of Science ®Google Scholar
• Patarroyo M, Prieto J, Betty PG, et al. Adhesion-mediating molecules of human monocytes. Cell Immunol 1988; 113: 278–289
   PubMed Web of Science ®Google Scholar
• Prieto J, Beatty PG, Clark EA, et al. Molecules mediating adhesion of T and B cells, monocytes and granulocytes to vascular endothelial. Cell 1988; 63: 631–637
   Google Scholar
• Kishimoto T. Factors affecting B cell growth and differentiation. Ann Rev Immunol 1985; 3: 133–152
   PubMed Web of Science ®Google Scholar
• Snapper CM, Paul WE. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987; 236: 944–947
   PubMed Web of Science ®Google Scholar
• Anderson KC, Park K, Bates M, et al. Antigens on human plasma cells identified by monoclonal antibodies. J Immunol 1983; 130: 1132–1138
   PubMed Web of Science ®Google Scholar
• Kersey JH, LeBien TW, Abramson CS, et al. A human hemopoietic progenitor and acute lymphoblastic leukemia-associated cell surface structure identified with a monoclonal antibody. J Exp Med 1981; 153: 24, 726–731
   Google Scholar
• Greaves MF, Verbi W, Vogler LB, et al. Antigenic and enzymatic phenotypes of the pre-b subclass of acute leukemia. Leuk Res 1980; 3: 353–362
   Web of Science ®Google Scholar
• Vogler LB, Crist WM, Bockman DE, et al. Pre-B cell leukemia: a new phenotype of childhood lymphoblastic leukemia. N Engl J Med 1978; 298: 872–878
   PubMed Web of Science ®Google Scholar
• Nadler LM, Ritz J, Bates MP, et al. Induction of human B cell antigens in non-T acute lymphoblastic leukemia. J Clin Invest 1982; 70: 433–442
   PubMed Web of Science ®Google Scholar
• Cossman J, Neckers LM, Arnold A, et al. Induction of differentiation in a case of common acute lymphoblastic leukemia. N Engl J Med 1982; 307: 1251–1254
   PubMed Web of Science ®Google Scholar
• Koziner B, Gebhard D, Denny T, et al. Characterization of B cell type chronic lymphocytic leukemia cells by surface markers and a monoclonal antibody. Am J Med 1982; 73: 802–807
   PubMed Web of Science ®Google Scholar
• Anderson KC, Bates MP, Slaughenhoupt BL, et al. Expression of human B cell associated antigens on leukemias and lymphomas: A model of B cell differentiation. Blood 1984; 63: 1424–1431
   PubMed Web of Science ®Google Scholar
• Arnold A, Cossman J, Bakhshi A, et al. Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. N Engl J Med 1983; 309: 1593–1599
   PubMed Web of Science ®Google Scholar
• Martin PJ, Hansen JA, Nowinski RC, et al. A new human T cell differentiation antigen: Unexpected expression on chronic lymphocytic leukemia cells. Immunogenetics 1980; 11: 429–439
   PubMed Web of Science ®Google Scholar
• Boumsell L, Coppin H, Pham D, et al. An antigen shared by a human T cell subset and B cell chronic lymphocytic leukemic cells. J Exp Med 1980; 152: 229–234
   PubMed Web of Science ®Google Scholar
• Martin PJ, Hansen JA, Siakak AW, et al. Monoclonal antibodies recognizing normal human T lymphocytes and malignant B lymphocytes: A comparative study. J Immunol 1981; 127: 1920–1923
   PubMed Web of Science ®Google Scholar
• Kamoun M, Kadin MF, Martin PJ, et al. A novel human T cell antigen preferentially expressed on mature T cells and also on (B type) chronic lymphatic leukemic cells. J Immunol 1981; 127: 987–996
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F, Gobbi M, Bofill M, et al. Infrequent normal B lymphocytes express features of B chronic lymphocytic leukemia. J Exp Med 1982; 155: 623–627
   PubMed Web of Science ®Google Scholar
• Ault KA, Antin JH, Ginsburg D, et al. Phenotype of recovering lymphoid cell populations after marrow transplantation. J Exp Med 1985; 161: 1483–1502
   PubMed Web of Science ®Google Scholar
• Bofill M, Janossy G, Janossa M, et al. Human B cell development, II. Subpopulations in the human fetus. J Immunol 1985; 134: 1531–1538
   PubMed Web of Science ®Google Scholar
• Griffin JD, Nadler LM. Immunobiology of chronic leukemias. Neoplastic Diseases of the Blood., PK. Wiernick, GP. Cancellos, RA. Kyle, et al. Churchill Livingstone, New York 1985; 51–96
   Google Scholar
• Catovsky D, Cherchi M, Okos A, et al. Mouse red blood cell rosettes in B lymphoproliferative disorders. Br J Haematol 1976; 33: 173–177
   PubMed Web of Science ®Google Scholar
• Brooks DA, Beckman IGR, Bradley J, et al. Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. IV. A monoclonal antibody reacting specifically with subpopulation of human B lymphocytes. J Immunol 1981; 126: 1373–1377
   PubMed Web of Science ®Google Scholar
• Catovsky D, Cherchi M, Brooks D, et al. Heterogeneity of B-cell leukemias demonstrated by the monoclonal antibody FMC7. Blood 1981; 58: 406–408
   PubMed Web of Science ®Google Scholar
• Jaffe ES, Berard CW. Lymphoblastic lymphoma, a term rekindled with new precision. Ann Intern Med 1978; 89: 415–417
   PubMed Web of Science ®Google Scholar
• Dorken B, Pezzutto A, Hunstein W. Expression of cytoplasmic CD22 in B cell ontogeny. Leukocyte Typing III., AJ. McMichael. Oxford University Press, Oxford 1987; 474–476
   Google Scholar
• Porwit-Ksiazek A, Christerson B, Lindemalm C, et al. Characterization of malignant and non-neoplastic cell phenotypes in highly malignant non-Hodgkin's lymphomas. Int J Cancer 1983; 32: 667–674
   PubMed Web of Science ®Google Scholar
• Kvaloy S, Langholm R, Kaalbus O, et al. Transferrin receptor and B-lymphoblast antigen-their relationship to DNA synthesis, histology and survival in B-cell lymphomas. Int J Cancer 1984; 33: 173–177
   PubMed Web of Science ®Google Scholar
• Mann RB, Jaffe ES, Braylen RC, et al. Non-endemic Burkitt's lymphoma: A B cell tumor related to germinal cancers. N Engl J Med 1976; 295: 685–691
   PubMed Web of Science ®Google Scholar
• Harris NL, Nadler LM, Bhan AK. Immunologic characterization of two malignant lymphomas of germinal center type (centroblastic/centrocytic and centrocytic) with monoclonal antibodies. Am J Pathol 1984; 117: 262–272
   PubMed Web of Science ®Google Scholar
• Murray LJ, Halbeshaw JA, Wiels J, et al. Expression of Burkitt lymphoma-associated antigen (defined by the monoclonal antibody 38:13) on both normal and malignant germinal-centre B cells. Int J Cancer 1985; 36: 561–565
   PubMed Web of Science ®Google Scholar
• Jaffe ES, Shevach EM, Frank MM, et al. Nodular lymphoma-evidence for origin from follicular B lymphocytes. N Engl J Med 1974; 290: 814–819
   Web of Science ®Google Scholar
• Cossman J, Jaffe ES. Distribution of complement receptor subtypes in non-Hodgkin's lymphomas of B cell origin. Blood 1981; 58: 20–26
   PubMed Web of Science ®Google Scholar
• Stein H, Siemssen V, Lennert K. Complement receptor subtypes C3b and C3d in lymphocytic tissue and follicular lymphoma. Br J Cancer 1978; 37: 520–532
   PubMed Web of Science ®Google Scholar
• Aisenberg AC, Wilkes BM, Harris NL. Monoclonal antibody studies in non-Hodgkin's lymphoma. Blood 1983; 61: 461–475
   Google Scholar
• Cossman J, Neckers LM, Longo D, et al. Low grade lymphomas: Expression of developmentally regulated B cell antigens. Am J Pathol 1984; 115: 117–124
   PubMed Web of Science ®Google Scholar
• Bhan AK, Nadler LM, Stashenko P, et al. Stages of B cell differentiation in human lymphoid tissues. J Exp Med 1981; 154: 737–749
   PubMed Web of Science ®Google Scholar
• Stein H, Gerdes J, Mason DY. The normal and malignant germinal centre. Clin Haematol 1982; 11: 531–559
   PubMedGoogle Scholar
• Freedman AS, Boyd AW, Anderson KC, et al. Immunologic heterogeneity of diffuse large cell lymphoma. Blood 1985; 65: 630–637
   PubMed Web of Science ®Google Scholar
• Van der Valk P, van den Besselaar-Dingian G, Daha MR, et al. Analysis of large cell lymphomas using monoclonal and heterologous antibodies. J Clin Pathol 1983; 36: 44–50
   PubMed Web of Science ®Google Scholar
• Pinkus GS, Said JW. Characterization of non-Hodgkin's lymphomas using multiple cell markers: Immunologic morphologic, and cytochemical studies of 72 cases. Am J Pathol 1978; 94: 349–380
   Web of Science ®Google Scholar
• Horning SJ, Doggert RS, Warnke RA, et al. Clinical relevance of immunologic phenotype in diffuse large cell lymphoma. Blood 1984; 63: 1209–1215
   PubMed Web of Science ®Google Scholar
• Stashenko P, Nadler LM, Hardy R, et al. Expression of cell surface markers following human B cell activation. Proc Natl Acad Sci (USA) 1981; 78: 3848–3852
   PubMed Web of Science ®Google Scholar
• Habeshaw JA, Lister TA, Starsfield AC. Correlation of transferrin receptor expression with histologic class and outcome in non-Hodgkin's lymphoma. Lancet 1983; 1: 498–501
   PubMed Web of Science ®Google Scholar
• Rudders RA, DeLellis RA, Ahl ET, et al. Adult non-Hodgkin's lymphoma correlation of cell surface markers phenotype with prognosis, the new working formulation, and the Rappaport and Ludes-Collins histomorphologic schemes. Cancer 1983; 52: 2289–2299
   PubMed Web of Science ®Google Scholar
• Catovsky D, Pettit JE, Galetto J, et al. The B-lymphocyte nature of the hairy cell of leukemia reticuloendotheliosis. Br J Haematol 1974; 26: 29–37
   PubMed Web of Science ®Google Scholar
• Korsmeyer SJ, Greene WC, Cossman, et al. Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proc Natl Acad Sci (USA) 1983; 80: 4522–4526
   PubMed Web of Science ®Google Scholar
• Divine M, Farcet JP, Gourdin MF, et al. Phenotype study of fresh and cultured hairy cells with the use of immunologic markers and electron microscopy. Blood 1984; 64: 547–552
   PubMed Web of Science ®Google Scholar
• Anderson KC, Boyd AW, Fisher DC, et al. Hairy cell leukemia: A tumor of pre-plasma cells. Blood 1985; 65: 620–629
   PubMed Web of Science ®Google Scholar
• Posnett DN, Wang CY, Chiorazzi N, et al. An antigen characteristic of hairy cell leukemia cells is expressed on certain activated B cells. J Immunol 1985; 133: 1635–1640
   Web of Science ®Google Scholar
• Schwarting R, Stein H, Wang CY. The monoclonal antibodies alpha-S-HCL1 (alpha-leu-14) and alpha-S-HCL3 (alpha-leu-M5) allow the diagnosis of hairy cell leukemia. Blood 1985; 65: 974–983
   PubMed Web of Science ®Google Scholar
• Robb RJ, Greene WC, Rusk CM. Low and high affinity cellular receptors for interleukin-2. J Exp Med 1984; 160: 1126–1146
   PubMed Web of Science ®Google Scholar
• Ford RJ, Yoshimura L, Morgan J, et al. Growth factor-mediated tumor cell proliferation in hairy cell leukemia. J Exp Med 1985; 162: 1093–1098
   PubMed Web of Science ®Google Scholar
• Hokland P, Kucharska-Pulczynska M, Ellegaard J. Analysis of leukocyte differentiation antigens in blood and bone marrow from patients with Waldenström's macroglobulinemia. Leukocyte Typing III., AJ. McMichael. Oxford University Press, Oxford 1987; 512–515
   Google Scholar
• Pilarski LM, Mant MJ, Ruether BA. Pre-B cells in peripheral blood of multiple myeloma patients. Blood 1985; 66: 416–422
   PubMed Web of Science ®Google Scholar
• Goldstein M, Hoxie J, Zembryki D, et al. Phenotypic and functional analysis of B cell lines from patients with multiple myeloma. Blood 1985; 66: 444–446
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F, Bergui L, Tesio L, et al. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. J Clin Invest 1985; 76: 1243–1251
   PubMed Web of Science ®Google Scholar
• Anderson T, Chabner BA, Young RC, et al. Malignant lymphoma I. The histology and staging of 473 patients at the National Cancer Institute. Cancer 1982; 50: 2699–2707
   PubMed Web of Science ®Google Scholar
• Benjamin D, Magrath IT, Douglass EC, et al. Derivation of lymphoma cell lines from microscopically normal bone marrow in patients with undifferentiated lymphomas: Evidence of occult bone marrow involvement. Blood 1983; 61: 1017–9
   PubMed Web of Science ®Google Scholar
• Jansen J, Falkenburg JHF, Stephan DE, et al. Removal of neoplastic cells from autologous bone marrow grafts with monoclonal antibodies. Sem Hematol 1984; 21: 164–81
   PubMed Web of Science ®Google Scholar
• Bast RC, Jr, Ritz J, Lipton, et al. Elimination of leukemia cells from human bone marrow using monoclonal antibody and complement. Cancer Res 1983; 43: 1389–94
   PubMed Web of Science ®Google Scholar
• Bast RC, Jr, DeFabritiis P, Lipton J, et al. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement. Cancer Res 1985; 45: 499–503
   PubMed Web of Science ®Google Scholar
• LeBien TW, Stephen DE, Bartholomew RM, et al. Utilization of a colony assay to assess the variables influencing elimination of leukemic cells from human bone marrow with monoclonal antibodies and complement. Blood 1985; 65: 945–50
   PubMed Web of Science ®Google Scholar
• Baumgartner C, Imbach P, Luthy A, et al. Autologous bone marrow transplantation for Stage IV abdominal non-Hodgkin's lymphnoma after in vitro purging with anti-Y 29/55 monoclonal antibody and complement. Monoclonal Antibodies and Cancer. Academic Press, New York 1983; 73–79
   Google Scholar
• Forster HK, Gudat FG, Girad MF, et al. Monoclonal antibody against a membrane antigen characterizing human leukemic B lymphocytes. Cancer Res 1982; 42: 1927–34
   PubMed Web of Science ®Google Scholar
• Netzel B, Haas RJ, Rodt H, et al. Immunologic conditioning of bone marrow for autotransplantation in childhood acute lymphoblastic leukemia. Lancet 1980; 1: 1332–1334
   PubMedGoogle Scholar
• Ritz J, Sallan SE, Bast RC, et al. Autologous bone marrow transplantation in CALLA positive acute lymphoblastic leukemia after in vitro treatment with 15 monoclonal antibody and complement. Lancet 1982; 2: 60–63
   PubMed Web of Science ®Google Scholar
• Soiffer RJ, Billet AL, Roy DC, . Autologous bone marrow transplantation for acute lymphoblastic leukemia in second or greater complete remission. Autologous Bone Marrow Transplantation, Procedeings of the Fifth International Symposium., KA. Dicke, J. Armitage, et al, in press
   Google Scholar
• Kersey SH, Weisdorf D, Nesbit ME, et al. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. N Engl J Med 1987; 317: 461–467
   PubMed Web of Science ®Google Scholar
• Appelbaum FR, Herzig GP, Ziegler JL, et al. Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood 1978; 52: 85–85
   PubMed Web of Science ®Google Scholar
• Gorin NC, David R, Stachowiak J, et al. High dose chemotherapy and autologous bone marrow transplantation in acute leukemias, malignant lymphomas, and solid tumors. Eur J Cancer 1981; 17: 557–568
   PubMed Web of Science ®Google Scholar
• Appelbaum FR, Fefer A, Cheever MA, et al. Treatment of non-Hodgkin's lymphoma with marrow transplantation in identical twins Blood. 1981; 58: 509–513
   Google Scholar
• Appelbaum FR, Thomas ED. Review of the use of marrow transplantation in the treatment of non-Hodgkin's lymphoma. J Clin Oncol 1983; 1: 440–447
   PubMed Web of Science ®Google Scholar
• Phillips GL, Herzig RH, Lazarus HM, et al. Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrow. N Engl J Med 1984; 310: 1557–1561
   PubMed Web of Science ®Google Scholar
• Takvorian T, Canellos GP, Ritz J, et al. Prolonged disease-free survival in patients with poor prognosis non-Hodgkin's lymphoma following autologous bone marrow transplantation. N Engl J Med 1987; 316: 1499–1505
   PubMed Web of Science ®Google Scholar
• Freedman AS, Takrovian T, Anderson KC, et al. Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse. J Clin Oncol 1990; 8: 784–791
   PubMed Web of Science ®Google Scholar
• Anderson KC, Ritz J, Takvorian T, et al. Hematologic engraftment and immune reconstitution post-transplantation with anti-B1 purged autologous bone marrow. Blood 1987; 69: 597–604
   PubMed Web of Science ®Google Scholar
• Philip T, Biron P, Philip I, et al. Massive therapy and autologous bone marrow transplantation in pediatric and young adults Burkitt's lymphoma (30 courses on 28 patients):a 5-year experience. Eur J Cancer Clin Oncol 1986; 22: 1015–1027
   PubMedGoogle Scholar
• Rohatiner AZS, Barnett MJ, Arnott S, et al. Ablative therapy supported by autologous bone marrow transplantation with in vitro treatment of marrow in patients with B cell malignancy. Blood 1986; 68: 241a
   Google Scholar
• Hurd D, LeBiea TW, Peterson B, et al. Intensive therapy and autologous bone marrow support for the treatment of refractory non-Hodgkin's lymphoma. Proc Am Soc Clin Oncol 1986; 5: 193
   Google Scholar
• Baumgartner C, Brundel ReG, Forster HK, . Autologous bone marrow transplantation for pediatric non-Hodgkin's lymphoma: in vitro purging of the graft with anti-Y 29/55 monoclonal antibody and complement. Autologous Bone Marrow Transplantation, Procedeings of the First International Symposium., KA. Dicke, G. Spitzer, AR. Zander, et al. University of Texas, M.D. Anderson Cancer Center, Houston 1985; 377–381
   Google Scholar